Ceva retains pricing premium on euros, Grifols does without
Ceva Sante Animale launched an €818m transatlantic loan package on Monday, as it seeks to refinance the capital structure it set up in 2007. But while another transatlantic deal — $4.8bn for Spanish pharmaceuticals company Grifols — achieved the same margin on its euro and dollar tranches late last week, Ceva has retained the traditional 25bp premium on the euro debt over the dollars.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts